BioSpace News Archive

Dr. Reddy’s Laboratories Ltd. today announced the launch of Deferasirox Tablets for Oral Suspension, a therapeutically equivalent generic version of Exjade® Tablets for Oral Suspension, approved by the U.S. Food and Drug Administration.

Applied Therapeutics Inc. (Nasdaq:APLT), today announced the presentation of data at the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) in Los Angeles (December 4-7, 2019) on AT-001, a novel, potent and selective aldose reductase inhibitor (ARI) in Phase 3 clinical development for Diabetic Cardiomyopathy (DbCM).

Ann & Robert H. Lurie Children’s Hospital of Chicago today announced its Board of Directors has elected Thomas Shanley, MD, as President and CEO, effective immediately.

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing treatments for central nervous system (CNS) disorders, will present the latest data on its antiepileptic drug (AED) cenobamate at the American Epilepsy Society (AES) 2019 Annual Meeting in Baltimore, Maryland (December 6 — 10, 2019).

Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients, announced that founder Dr. Suzanne Ildstad will present a poster at the American Society of Hematology annual meeting, taking place December 7-10, 2019, in Orlando, Fla.

BVI, one of the fastest growing diversified companies in ophthalmology, today announced it has acquired Arcadophtha SARL (Arcad), a France-based ophthalmic company specializing in silicon oils, gases and perfluorocarbons used in vitreoretinal surgery.

Gilero, a contract design, development and manufacturing firm specializing in medical and drug delivery devices, has announced the opening of a new Design Center in Carlsbad, California